ISOPI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 434
EU - Europa 274
AS - Asia 58
OC - Oceania 3
SA - Sud America 1
Totale 770
Nazione #
US - Stati Uniti d'America 434
IT - Italia 95
SE - Svezia 52
IE - Irlanda 50
CN - Cina 30
UA - Ucraina 19
FR - Francia 16
GB - Regno Unito 11
DE - Germania 10
TR - Turchia 9
BE - Belgio 8
VN - Vietnam 6
IN - India 5
AU - Australia 3
KR - Corea 3
ES - Italia 2
FI - Finlandia 2
IR - Iran 2
JP - Giappone 2
NL - Olanda 2
PL - Polonia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SG - Singapore 1
Totale 770
Città #
Chandler 107
Dublin 49
Ann Arbor 40
Ashburn 37
Jacksonville 32
Princeton 28
Chieti 25
Dearborn 21
Houston 17
New York 11
Altamura 10
Rome 10
Wilmington 10
San Mateo 9
San Vito Chietino 9
Brussels 8
Washington 8
Woodbridge 8
Beijing 6
Dong Ket 6
Nanjing 6
Boardman 4
Izmir 4
Jiaxing 4
Napoli 4
Rochester 4
Southend 4
Los Angeles 3
Saint-Saens 3
Aprilia 2
Augusta 2
Cambridge 2
Milan 2
Nanchang 2
Redwood City 2
Rouen 2
San Cristóbal de La Laguna 2
Sinalunga 2
Tianjin 2
Tokyo 2
Woburn 2
Adelaide 1
Antalya 1
Baotou 1
Bari 1
Belgrade 1
Cachan 1
Changsha 1
Charlotte 1
Collecorvino 1
Denver 1
Edinburgh 1
Giresun 1
Haikou 1
Hebei 1
Helsinki 1
Hoffman 1
Jinan 1
Jinhua 1
Kunming 1
Kurrara 1
Lanciano 1
Lanzhou 1
Lisbon 1
Ningbo 1
Norwalk 1
Oslo 1
Paris 1
Pescara 1
Piotrkow Trybunalski 1
Pittsburgh 1
Prague 1
Prato 1
Rio de Janeiro 1
San Salvo 1
Santa Clara 1
Scarlino 1
Seattle 1
Shaoxing 1
Sydney 1
Warsaw 1
Totale 551
Nome #
Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology 159
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 119
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 73
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 71
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 70
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 65
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 63
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 51
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 51
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 51
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 41
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 39
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 28
Totale 881
Categoria #
all - tutte 3.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201913 0 0 0 0 0 0 0 0 0 0 3 10
2019/2020115 29 4 1 1 11 14 22 5 2 7 15 4
2020/2021139 3 8 13 7 10 15 8 5 30 17 11 12
2021/2022133 5 7 1 28 9 1 4 11 6 6 22 33
2022/2023257 20 36 19 34 24 37 10 22 30 5 9 11
2023/2024150 5 6 11 9 14 37 18 25 6 19 0 0
Totale 881